Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	99.85	-4.13	-2696.20
Graham Fair Price	-31.33	108.21	157.59
PEG	1090.48	0.04	< 0.005
Price/Book	11.59	0.77	0.69
Price/Cash Flow	-64.26	-6.06	16.96
Prices/Earnings	-76.16	-1.63	-0.92
Price/Sales	843.24	43.40	4.60
Price/FCF	-64.26	-6.06	16.96
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-613402.70	-8.32	< 0.005
ROA	46.61	< 0.005	< 0.005
ROE	-0.19	-0.12	36.65
ROIC	< 0.005	-0.07	-102615.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-0.03
Dividends QOQ	-0.02	0.06	208.46
EBIT QOQ	-1.00	-615.00	-61267.46
EPS QOQ	-3.06	0.45	-85.20
FCF QOQ	-0.85	-3.65	-330.53
Revenue QOQ	-0.37	-0.90	-143.08
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	2416.45	24642.97	919.80
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.59	0.43	-26.83
Quick Ratio	7.53	7.86	4.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	77.14	66.55	-13.73
Cash	122.44	134.22	9.63
Capex	0.75	0.00	inf
Free Cash Flow	3.12	-8.41	169.39
Revenue	11.50	1.17	-89.79
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.85	8.22	4.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	695.00	1.08	-99.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating